180 related articles for article (PubMed ID: 37256494)
1. Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis.
de Ruiter MB; Deardorff RL; Blommaert J; Chen BT; Dumas JA; Schagen SB; Sunaert S; Wang L; Cimprich B; Peltier S; Dittus K; Newhouse PA; Silverman DH; Schroyen G; Deprez S; Saykin AJ; McDonald BC
Brain Imaging Behav; 2023 Oct; 17(5):507-518. PubMed ID: 37256494
[TBL] [Abstract][Full Text] [Related]
2. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
[TBL] [Abstract][Full Text] [Related]
3. Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.
Chen BT; Jin T; Patel SK; Ye N; Sun CL; Ma H; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Somlo G; Vazquez J; Levi A; Tan H; Yang R; Katheria V; Hurria A
Breast Cancer Res Treat; 2018 Nov; 172(2):363-370. PubMed ID: 30088178
[TBL] [Abstract][Full Text] [Related]
4. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.
McDonald BC; Conroy SK; Ahles TA; West JD; Saykin AJ
Breast Cancer Res Treat; 2010 Oct; 123(3):819-28. PubMed ID: 20690040
[TBL] [Abstract][Full Text] [Related]
5. Reduced Gray Matter Volume of the Thalamus and Hippocampal Region in Elderly Healthy Adults with no Impact of APOE ɛ4: A Longitudinal Voxel-Based Morphometry Study.
Squarzoni P; Duran FLS; Busatto GF; Alves TCTF
J Alzheimers Dis; 2018; 62(2):757-771. PubMed ID: 29480170
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
7. Regional brain gray and white matter changes in perinatally HIV-infected adolescents.
Sarma MK; Nagarajan R; Keller MA; Kumar R; Nielsen-Saines K; Michalik DE; Deville J; Church JA; Thomas MA
Neuroimage Clin; 2014; 4():29-34. PubMed ID: 24380059
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal gray matter changes of the pain matrix in patients with carbon monoxide intoxication: A voxel-based morphometry study.
Chou MC; Li JY; Lai PH
Eur J Radiol; 2020 May; 126():108968. PubMed ID: 32203827
[TBL] [Abstract][Full Text] [Related]
9. Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy.
McDonald BC; Van Dyk K; Deardorff RL; Bailey JN; Zhai W; Carroll JE; Root JC; Ahles TA; Mandelblatt JS; Saykin AJ
Breast Cancer Res Treat; 2022 Jul; 194(1):113-126. PubMed ID: 35476252
[TBL] [Abstract][Full Text] [Related]
10. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
McDonald BC; Conroy SK; Smith DJ; West JD; Saykin AJ
Brain Behav Immun; 2013 Mar; 30 Suppl(0):S117-25. PubMed ID: 22613170
[TBL] [Abstract][Full Text] [Related]
11. Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study.
Correa DD; Root JC; Kryza-Lacombe M; Mehta M; Karimi S; Hensley ML; Relkin N
Brain Imaging Behav; 2017 Dec; 11(6):1652-1663. PubMed ID: 27766586
[TBL] [Abstract][Full Text] [Related]
12. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation.
Asami T; Bouix S; Whitford TJ; Shenton ME; Salisbury DF; McCarley RW
Neuroimage; 2012 Jan; 59(2):986-96. PubMed ID: 21924364
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy increases temporal gray matter volume and cortical thickness.
Sartorius A; Demirakca T; Böhringer A; Clemm von Hohenberg C; Aksay SS; Bumb JM; Kranaster L; Ende G
Eur Neuropsychopharmacol; 2016 Mar; 26(3):506-17. PubMed ID: 26792445
[TBL] [Abstract][Full Text] [Related]
15. Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose.
Nagtegaal SHJ; David S; van Grinsven EE; van Zandvoort MJE; Seravalli E; Snijders TJ; Philippens MEP; Verhoeff JJC
Clin Transl Radiat Oncol; 2021 Nov; 31():14-20. PubMed ID: 34504960
[TBL] [Abstract][Full Text] [Related]
16. Frontal gray matter abnormalities predict seizure outcome in refractory temporal lobe epilepsy patients.
Doucet GE; He X; Sperling M; Sharan A; Tracy JI
Neuroimage Clin; 2015; 9():458-66. PubMed ID: 26594628
[TBL] [Abstract][Full Text] [Related]
17. Early alterations in cortical morphology after neoadjuvant chemotherapy in breast cancer patients: A longitudinal magnetic resonance imaging study.
Zhou X; Tan Y; Yu H; Liu J; Lan X; Deng Y; Yu F; Wang C; Chen J; Zeng X; Liu D; Zhang J
Hum Brain Mapp; 2022 Oct; 43(15):4513-4528. PubMed ID: 35665982
[TBL] [Abstract][Full Text] [Related]
18. Structural brain alteration in survivors of acute lymphoblastic leukemia with chemotherapy treatment: A voxel-based morphometry and diffusion tensor imaging study.
Zou L; Su L; Xu J; Xiang L; Wang L; Zhai Z; Zheng S
Brain Res; 2017 Mar; 1658():68-72. PubMed ID: 28109978
[TBL] [Abstract][Full Text] [Related]
19. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
Meijboom R; York EN; Kampaite A; Harris MA; White N; Valdés Hernández MDC; Thrippleton MJ; MacDougall NJJ; Connick P; Hunt DPJ; Chandran S; Waldman AD;
PLoS One; 2023; 18(7):e0288967. PubMed ID: 37506096
[TBL] [Abstract][Full Text] [Related]
20. Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy.
Alvim MK; Coan AC; Campos BM; Yasuda CL; Oliveira MC; Morita ME; Cendes F
Epilepsia; 2016 Apr; 57(4):621-9. PubMed ID: 26865066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
